Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LESTAURTINIB for Acute lymphocytic leukaemia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 64 adverse event reports in the FDA FAERS database where LESTAURTINIB was used for Acute lymphocytic leukaemia.

Most Reported Side Effects for LESTAURTINIB

Side Effect Reports % Deaths Hosp.
Febrile neutropenia 23 28.8% 0 23
Hypertriglyceridaemia 13 16.3% 10 5
Clostridium difficile colitis 10 12.5% 0 10
Death 10 12.5% 10 5
Diarrhoea 10 12.5% 0 10
Enterococcal infection 9 11.3% 0 9
Sepsis 9 11.3% 0 9
Bronchiolitis 8 10.0% 0 8
Candida infection 8 10.0% 0 8
Hypertension 8 10.0% 0 8
Klebsiella infection 8 10.0% 0 8
Otitis externa 8 10.0% 0 8
Pulmonary oedema 8 10.0% 0 8
Septic shock 8 10.0% 0 8
Vomiting 8 10.0% 0 8

Other Indications for LESTAURTINIB

B precursor type acute leukaemia (5)

Other Drugs Used for Acute lymphocytic leukaemia

METHOTREXATE (11,187) VINCRISTINE (9,875) CYTARABINE (7,619) PEGASPARGASE (6,611) DEXAMETHASONE (6,461) CYCLOPHOSPHAMIDE (5,495) MERCAPTOPURINE (4,815) DOXORUBICIN (3,128) DAUNORUBICIN (3,111) BLINATUMOMAB (2,777)

Related Pages

LESTAURTINIB Full Profile All Acute lymphocytic leukaemia Drugs LESTAURTINIB Demographics LESTAURTINIB Timeline